Balchem Corp

Balchem Corp Stock Forecast & Price Prediction

Live Balchem Corp Stock (BCPC) Price



  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price


P/E Ratio


Volume Traded Today




52 Week High/low


Balchem Corp Market Cap


🛑 Alert: These ten stocks could have higher potential than $BCPC 🛑

Before you buy BCPC you’ll want to see this list of ten stocks that have huge potential. Want to see if BCPC made the cut? Enter your email below

BCPC Summary

The Balchem Corp (BCPC) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered BCPC. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for BCPC is a sell. Please note analyst price targets are not guaranteed and could be missed completely.

BCPC Analyst Ratings

About 0 Wall Street analysts have assigned BCPC 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Balchem Corp to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BCPC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

BCPC stock forecast by analyst



Price Target



ram selvaraju
H.C. Wainwright




Oct 30, 2023
mitra ramgopal




Feb 22, 2022
mark connelly




Aug 2, 2021
brett hundley
Seaport Global




Feb 21, 2019
mike ritzenthaler
Piper Sandler




Feb 2, 2016
daniel rizzo




Apr 1, 2014

BCPC Company Information

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Balchem Corp (BCPC)

When did it IPO


Staff Count



United States


Basic Materials/Specialty Chemicals


Mr. Theodore L. Harris

Market Cap


Balchem Corp (BCPC) Financial Data

In 2023, BCPC generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BCPC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020


Revenue From 2021


0.00 %
From Previous Year

Revenue From 2022


0.00 %
From Previous Year

Revenue From 2023


0.00 %
From Previous Year
  • Revenue TTM $922.4M
  • Operating Margin TTM 15.7%
  • Gross profit TTM $302.1M
  • Return on assets TTM 6.1%
  • Return on equity TTM 10.9%
  • Profit Margin 11.8%
  • Book Value Per Share 32.68%
  • Market capitalisation $4.96B
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 N/A
  • EPS this year (TTM) $3.35
... ...

Similar Stocks to Balchem Corp - BCPC

🛑 Alert: These ten stocks could have higher potential than $BCPC 🛑

Before you buy BCPC you’ll want to see this list of ten stocks that have huge potential. Want to see if BCPC made the cut? Enter your email below


BCPC Frequently asked questions

The highest forecasted price for BCPC is $ from at .

The lowest forecasted price for BCPC is $ from from

The BCPC analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.